High-dose anakinra to treat refractory immune effector cell-associated neurotoxicity syndrome in CAR T-cell therapy recipients
Emily C. Liang(Fred Hutch Cancer Center), Richard T. Maziarz(Oregon Health & Science University), Qiao Yang(Guangxi Medical University), Yein Jeon(University of Washington), Amrita Desai(Oregon Health & Science University), Jordan Gauthier(Seattle Cancer Care Alliance), Brandon Hayes‐Lattin(Oregon Health & Science University), Francesco Mazziotta(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Erik L. Kimble(University of Washington), Bashi Ratterree, Rebecca Silbermann(Oregon Health & Science University), Qian Wu(Cancer Research Center), Andrew J. Portuguese(University of Washington), Sanjog Bastola(Oregon Health & Science University), Jessica Leonard(Oregon Health & Science University), Aude G. Chapuis(University of Washington), Rachel Bixler, Brian G. Till(University of Washington), Alexandre V. Hirayama(University of Washington), Noam E. Kopmar(University of Washington), Eva Medvedova(Oregon Health & Science University), Gabrielle Meyers(Oregon Health & Science University), Eshana Shah(University of Washington), Filippo Milano(Fred Hutch Cancer Center), Jenna Voutsinas(Fred Hutch Cancer Center), Staci Williamson(Oregon Health & Science University), Edus H. Warren(University of Washington), Kate A. Markey(Cornell University), Ryan D. Cassaday(University of Washington), Smith Kungwankiattichai, Craig Okada(Oregon Health & Science University), Jennifer J. Huang(Stanford Medicine), Andy Chen(Stanford University), Xiancheng Wu(Fred Hutch Cancer Center), Mazyar Shadman(University of Washington), Jacqueline Trussell, Dwight Macero(University of Washington), Tanaya Shree(Memorial Sloan Kettering Cancer Center), Cheryl Stomberg, Stephen E. Spurgeon(Oregon Health & Science University)
Cited by 0
Related Papers
Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2013|1.7k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
|The Lancet|2021|795
IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion
|Genes & Development|2010|744
Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2020|739